Ensure your drug device or diagnostic product gets reimbursed

Ensure your drug, device or diagnostic product gets reimbursed

To support health technology assessment, Numerus combines rigorous statistical principles with health economics in a unified regulatory approach that successfully supports the reimbursement of drugs, medical devices and diagnostics.

Our team are internationally located, provide multi-lingual support and have a solid understanding of country-specific guidelines.

Numerus integrates analyses for effectiveness, cost, and utility modelling, into early clinical study design. We also ensure broad forethought into how best to address available HTA guidance.

Numerus delivers all the appropriate modelling and analyses.

Numerus’s partner for health economic modelling

Source HEOR is an independent health economics consultancy specialising in health economic modelling, data analysis for economic models, health technology assessment, and health economics training.

HTA Services
  • Meta-analyses, NMA & ITC
  • Event forecasting
  • HE models
    • Markov
    • Decision trees
    • Cost utility
    • Cost effectiveness
    • Budget impact
    • Probabilistic sensitivity analyses
  • Discrete event simulation
  • Conjoint analyses
  • Compliance checks
    • NICE
    • G-BA
    • IQWiG